Brief: Aileron Therapeutics Reports Closing Of Underwritten Registered Direct Offering Of Up To About $40 Million
03/05/2024 21:06
May 3 (Reuters) - Aileron Therapeutics Inc ALRN.O :
* AILERON THERAPEUTICS ANNOUNCES CLOSING OF UNDERWRITTEN
REGISTERED DIRECT OFFERING OF UP TO APPROXIMATELY $40 MILLION
Source text for Eikon: ID:nGNX2jGhXw
Further company coverage: ALRN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rein Therapeutics
See all newsBrief: Rein Therapeutics Receives U.S. FDA Fast Track Designation For Lti-03 In Idiopathic Pulmonary Fibrosis
Rein Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Rein Therapeutics Q2 net loss narrows on lower R&D spending
Rein Therapeutics Inc expected to post a loss of 17 cents a share - Earnings Preview
Brief: Rein Therapeutics Announces Closing Of $57.5 Million Underwritten Public Offering